comprehensive -WSS

comprehensive

author：fashion 2025-09-06 04:14:16 - browse：89372

The Blue Shield of California headquarters building is seen in San Francisco – health care policy from STAT — Eric Risberg/AP

Two dominant Blue Cross Blue Shield companies in California intentionally underreported premiums of certain health plans so they could avoid paying Affordable Care Act taxes, according to new federal whistleblower complaints.

These claims renew concerns about whether health insurance companies have skirted the tax code and to what extent tax fraud could exist in the industry.

Blue Shield of California evaded $111 million in taxes between 2016 and 2020, according to a complaint that was filed with the Internal Revenue Service on June 27. Elevance Health, the parent company of Anthem Blue Cross in California, evaded $60 million in taxes during the same time period, according to a separate complaint filed with the IRS.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Morphosys mixed study results for blood cancer drug

WSS

Congress must reauthorize a committee to support older Americans

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Experts study whether long Covid risk adds up with each reinfection

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

focus

comprehensive

focus

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Virginia high school admissions case could be legal follow

CRISPR pioneers react to Casgevy, first gene

Hepatitis C has a cure — but many Americans still lack access to it

The stability of $0 premiums in Medicare Advantage

Heart attack and stroke risk calculators need revising

Anthos stroke drug appears safer than common blood thinner

Drug repurposing or repositioning? The language matters

6 solutions to address cancer drug shortages and others

focus

CRISPR base editing slashes cholesterol levels in monkeys

Nobel honors Karikó and Weissman's enduring partnership

The biotech scorecard for Q4: 16 stock

Flu, Covid vaccination rates decline, new survey data show

Weight loss drug costs may need more research, senator suggests

Some top drug companies are starting to take action on climate

focus

leisure time

hotspot

Wikipedia